These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8097970)

  • 1. Neurohumoral activation in preclinical heart failure. Remodeling and the potential for intervention.
    Francis GS; McDonald KM; Cohn JN
    Circulation; 1993 May; 87(5 Suppl):IV90-6. PubMed ID: 8097970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial collagen matrix remodeling and congestive heart failure.
    Brilla CG; Rupp H
    Cardiologia; 1994 Dec; 39(12 Suppl 1):389-93. PubMed ID: 7634301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hypertrophy due to left cardiac insufficiency: role of the neurohumoral system].
    Lerch R; Montessuit C
    Praxis (Bern 1994); 1997 Feb; 86(7):238-41. PubMed ID: 9139340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Obesity and cardiac failure].
    Galinier M; Pathak A; Roncalli J; Massabuau P
    Arch Mal Coeur Vaiss; 2005 Jan; 98(1):39-45. PubMed ID: 15724418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changing the remodeling process in heart failure: basic mechanisms and laboratory results.
    Francis GS
    Curr Opin Cardiol; 1998 May; 13(3):156-61. PubMed ID: 9649937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neurohumoral regulation in heart failure].
    Riegger GA; Muders F; Luchner A
    Z Kardiol; 1996; 85 Suppl 6():205-10. PubMed ID: 9064967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Spironolactone: renaissance of anti-aldosterone therapy in heart failure?].
    Brilla CG; Schencking M; Scheer C; Rupp H
    Praxis (Bern 1994); 1997 Apr; 86(14):566-74. PubMed ID: 9198851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation between left ventricular remodeling and clinical outcomes in heart failure patients with left ventricular systolic dysfunction.
    Udelson JE; Konstam MA
    J Card Fail; 2002 Dec; 8(6 Suppl):S465-71. PubMed ID: 12555159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ventricular remodeling and its prevention in the treatment of heart failure.
    Patten RD; Udelson JE; Konstam MA
    Curr Opin Cardiol; 1998 May; 13(3):162-7. PubMed ID: 9649938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Influence of pacing site on myocardial transmural dispersion of repolarization in intact normal and dilated cardiomyopathy dogs].
    Bai R; Pu J; Liu N; Lu JG; Zhou Q; Ruan YF; Niu HY; Wang L
    Sheng Li Xue Bao; 2003 Dec; 55(6):722-30. PubMed ID: 14695492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amiodarone improves cardiac sympathetic nerve function to hold norepinephrine in the heart, prevents left ventricular remodeling, and improves cardiac function in rat dilated cardiomyopathy.
    Tachikawa H; Kodama M; Watanabe K; Takahashi T; Ma M; Kashimura T; Ito M; Hirono S; Okura Y; Kato K; Hanawa H; Aizawa Y
    Circulation; 2005 Feb; 111(7):894-9. PubMed ID: 15710769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurohormonal response to left ventricular reconstruction surgery in ischemic cardiomyopathy.
    Schenk S; McCarthy PM; Starling RC; Hoercher KJ; Hail MD; Ootaki Y; Francis GS; Doi K; Young JB; Fukamachi K
    J Thorac Cardiovasc Surg; 2004 Jul; 128(1):38-43. PubMed ID: 15224019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Src and multiple MAP kinase activation in cardiac hypertrophy and congestive heart failure under chronic pressure-overload: comparison with acute mechanical stretch.
    Takeishi Y; Huang Q; Abe J; Glassman M; Che W; Lee JD; Kawakatsu H; Lawrence EG; Hoit BD; Berk BC; Walsh RA
    J Mol Cell Cardiol; 2001 Sep; 33(9):1637-48. PubMed ID: 11549343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted deletion of nuclear factor kappaB p50 enhances cardiac remodeling and dysfunction following myocardial infarction.
    Timmers L; van Keulen JK; Hoefer IE; Meijs MF; van Middelaar B; den Ouden K; van Echteld CJ; Pasterkamp G; de Kleijn DP
    Circ Res; 2009 Mar; 104(5):699-706. PubMed ID: 19168865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The identification of contributory mechanisms for the development and progression of congestive heart failure in animal models.
    Iannini JP; Spinale FG
    J Heart Lung Transplant; 1996 Nov; 15(11):1138-50. PubMed ID: 8956123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of L-2286, a poly(ADP-ribose)polymerase inhibitor and enalapril on myocardial remodeling and heart failure.
    Bartha E; Kiss GN; Kalman E; Kulcsár G; Kálai T; Hideg K; Habon T; Sumegi B; Toth K; Halmosi R
    J Cardiovasc Pharmacol; 2008 Sep; 52(3):253-61. PubMed ID: 18806606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in the treatment of heart failure caused by left ventricular systolic dysfunction.
    Sander GE; McKinnie JJ; Greenberg SS; Giles TD
    Prog Cardiovasc Dis; 1999; 41(4):265-300. PubMed ID: 10362349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural remodelling in heart failure: gelatinase induction.
    Armstrong PW; Moe GW; Howard RJ; Grima EA; Cruz TF
    Can J Cardiol; 1994 Mar; 10(2):214-20. PubMed ID: 8143222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Left-ventricular hypertrophy as a cardiac risk factor: role of the renin-angiotensin-aldosterone system].
    Erne P
    Praxis (Bern 1994); 1996 Feb; 85(8):227-33. PubMed ID: 8701189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of chronic molecular and cellular abnormalities due to heart failure by passive mechanical ventricular containment.
    Sabbah HN; Sharov VG; Gupta RC; Mishra S; Rastogi S; Undrovinas AI; Chaudhry PA; Todor A; Mishima T; Tanhehco EJ; Suzuki G
    Circ Res; 2003 Nov; 93(11):1095-101. PubMed ID: 14563716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.